Luminescent nanomaterials have captured the imagination of scientists for a long time and offer great promise for applications in organic/inorganic light-emitting displays, optoelectronics, optical sensors, biomedical imaging, and diagnostics. Atomically precise gold clusters with well-defined core-shell structures present bright prospects to achieve high photoluminescence efficiencies. In this study, gold clusters with a luminescence quantum yield greater than 60% were synthesized based on the Au22(SG)18 cluster, where SG is glutathione, by rigidifying its gold shell with tetraoctylammonium (TOA) cations. Time-resolved and temperature-dependent optical measurements on Au22(SG)18 have shown the presence of high quantum yield visible luminescence below freezing, indicating that shell rigidity enhances the luminescence quantum efficiency. To achieve high rigidity of the gold shell, Au22(SG)18 was bound to bulky TOA that resulted in greater than 60% quantum yield luminescence at room temperature. Optical measurements have confirmed that the rigidity of gold shell was responsible for the luminescence enhancement. This work presents an effective strategy to enhance the photoluminescence efficiencies of gold clusters by rigidifying the Au(I)-thiolate shell.

The antifungal activity of polyvinylpyrrolidone (PVP)-stabilized quantum-sized silver nanoparticles (SNPs) against the growth of Candida albicans has been demonstrated in the present study. C. albicans is a known opportunistic human pathogen causing superficial and systemic infections. Research data carried out on C. albicans so far have shown unequivocally that it develops resistance against conventional antifungal drugs and that the infections it causes are difficult to cure with conventional antifungal agents. Hence, it is urgent to find newer materials for the treatment of infections caused by C. albicans that must be safe for the host. PVP-capped SNPs were synthesized, and its surface plasmon band was observed at 410 nm. The growth of C. albicans was markedly inhibited when the cells were incubated with SNP. The minimum inhibitory concentration (MIC) of SNP was determined as 70 ng/ml, and this value is relatively lower when compared with the conventionally used antifungal drugs such as amphotericin B (0.5 μg/ml), fluconazole (0.5 μg/ml), and ketoconazole (8 μg/ml). The viability of SNP-treated cells was checked by measuring the metabolic activity using XTT assay. Field emission scanning electron microscopic (FE-SEM) and transmission electron microscopic (TEM) analyses of the cells treated with SNP have lost the structural integrity to a greater extent.

We report MPS stabilized ultrasmall NiO NCs for high performance supercapacitors.

No abstract

No abstract